Atlas Venture Fund IX, L.P., 10% Owner at Intellia Therapeutics, Inc. (NTLA), sold 150,000 shares at $16.77 ($2.4M) on 2017-07-07, disclosed to the SEC on 2017-07-11.
Open-market sale of $2.4M NTLA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.77 | 30,000 | $503K | 20.7% |
| 2 | $16.17 | 40,000 | $647K | 26.6% |
| 3 | $16.07 | 80,000 | $1.3M | 52.8% |
| Total | $16.24 avg | 150,000 | $2.4M | 100% |